Clinical Trial Update: A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating subcutaneous Mircera for anemia in patients with chronic kidney disease not on dialysis; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2011-10-03